Glycemic variability in type 2 diabetic patients with metabolic dysfunction-associated steatotic liver disease: a case-control study
Aims A case-control study was conducted to assess glycemic variability (GV) in individuals diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2DM), as well as in those with either condition independently.Methods This study encompassed 2897...
Saved in:
| Main Authors: | Yueqiu Wang, Jing Liu, Yaoqin Yang, Qiong Wang, Yiqiong Sun, Ruiting Shen, Mingchen Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2548976 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypoglycemia and glycemic variability in acute myocardial infarction: the lesser-known aspects of glycemic control
by: Claudia Lucci, et al.
Published: (2025-07-01) -
Outcomes of coronary revascularization in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review
by: Jacob J. Gries, et al.
Published: (2025-08-01) -
A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease
by: Zülal İstemihan, et al.
Published: (2025-07-01) -
MIND diet score and its association with metabolic dysfunction-associated steatotic liver disease and gut microbiota profiles: a cross-sectional study
by: Shengbo Yang, et al.
Published: (2025-08-01) -
Association between glycemic variability and mortality in critically ill patients with heart failure
by: Pengcheng Liu, et al.
Published: (2025-08-01)